1st human clinical trial of artificial pancreas yields positive result

   Jun 11, 11:22 am

Washington, June 11 (ANI): Results from the first feasibility study of an advanced first-generation artificial pancreas system have indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System was able to automatically predict a rise and fall in blood glucose and correspondingly increase and-or decrease insulin delivery safely.

The HHM System included a continuous, subcutaneous insulin pump, a continuous glucose monitor (CGM) and special software used to predict changes in blood glucose.

It was conducted by Animas Corporation in collaboration with JDRF as part of an ongoing partnership to advance the development of a closed-loop artificial pancreas system for patients with Type 1 diabetes.

"The successful completion of this study using the HHM System in a human clinical trial setting is a significant step forward in the development of an advanced first-generation artificial pancreas system," Dr. Henry Anhalt, Animas Chief Medical Officer and Medical Director of the Artificial Pancreas Program, said.

"It lays the foundation for subsequent clinical trials, bringing us one step closer to making the dream of an artificial pancreas a reality for millions of people living with Type 1 diabetes," he said.

In June 2011, Animas received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to proceed with human clinical feasibility studies for the development of a closed-loop artificial pancreas system.

The company partnered with the JDRF in January 2010 to begin developing such an automated system to help people living with Type 1 diabetes better control their disease.

"We are encouraged by the results of the first human trials in this partnership with Animas," Aaron Kowalski, Assistant Vice President of Research at JDRF, said.

"An artificial pancreas system that can not only detect, but can predict high and low blood sugar levels and make automatic adjustments to insulin delivery would be a major advance for people with Type 1 diabetes. Such a system could alleviate a huge burden of managing this disease," Kowalski said.

The trial was a non-randomized, uncontrolled feasibility study of 13 participants with Type 1 diabetes at one trial site in the United States. The investigational Hypoglycemia-Hyperglycemia Minimizer (HHM) system was studied for approximately 24 hours for each study participant during periods of open and closed loop control via a model predictive control algorithm with a safety module run from a laptop platform.

Insulin and food variables were manipulated throughout the study time period to challenge and assess the system.

The primary endpoint was to evaluate the ability of the algorithm to predict a rise and fall in glucose above or below set thresholds and to command the pump to increase, decrease, suspend and/or resume insulin infusion accordingly.

The secondary endpoint was to understand the HHM system's ability to safely keep glucose levels within a target range and to provide guidance for future system development. The study also examined the relationship between CGM trends and the control model's algorithm for insulin delivery.

The findings were presented today at the 72nd Annual American Diabetes Association Meeting in Philadelphia. (ANI)

Asteroid that made dinosaurs extinct almost wiped off mammals too Dec 18, 1:17 pm
Washington, Dec 18 (ANI): A new study has shed light on an asteroid that wiped out dinosaurs may have wiped out mammals as well.
Full Story
Science community happy over successful launch of GSLV Mark-III Dec 18, 1:14 pm
New Delhi, Dec. 18 (ANI): Senior scientist and SPACE India director C B Devgun on Thursday expressed happiness over the successful launch of Geosynchronous Satellite Launch Vehicle (GSLV) Mark-III, adding that this was the first test done without the cryogenic engine and that the new module CREW that has been crafted to ensure the safe arrival of astronauts back to earth, had been tested successfully.
Full Story
Substance from broccoli can help ward off premature ageing Dec 18, 1:14 pm
Washington, Dec 18 (ANI): A team of scientists has revealed that Hutchinson-Gilford Progeria Syndrome (HGPS) related defects can be reduced with the help of a substance found in broccoli.
Full Story
Longer we take to decide, the less accurate and confident we get Dec 18, 12:28 pm
Washington, Dec 18 (ANI): A team of neuroscientists has found that the longer people take to decide, the less accurate and confident they are.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY